SOMERSET, N.J., February 1, 2021 – Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has accepted a request […]

SOMERSET, N.J., December 15, 2020 – Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will participate virtually in the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021. Ying Huang, PhD, Chief Executive Officer […]

Legend Biotech also achieves fifth milestone payment under its collaboration agreement with Janssen in clinica development of cilta-cel SOMERSET, N.J., December 21, 2020 – Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today the initiation […]

Piscataway, NJ, February 1, 2019 – Legend Biotech USA, Inc (“Legend”) announced today that the company has recently joined the American Society for Blood and Marrow Transplantation (ASBMT™) Corporate Council. Representatives from Legend plan to actively participate in ASBMT Corporate Council forums. Participation in the ASBMT Corporate Council provides Legend Biotech with the opportunity to […]

Sandyford, Dublin, March 5, 2019 – Legend Biotech Ireland, Ltd. announces the official opening of the company’s European headquarters (HQ) at 10A Ballymoss Road, Sandyford Business Park, Dublin 18, Ireland. Legend Biotech established their European HQ in Dublin at the end of 2017 and has been focusing primarily on research and development (R & D) […]